Aptamers and antibodies: rivals or allies in cancer targeted therapy?
{{output}}
The goal of an efficacious cancer therapy is to specifically target diseased cells at high accuracy while sparing normal, healthy cells. Over the past three decades, immunotherapy, based on the use of monoclonal antibodies (mAbs) directed against tumor-associa... ...